miR-221 silencing blocks hepatocellular carcinoma and promotes survival

Patients with advanced hepatocellular carcinoma (HCC) face a dismal prognosis due to a lack of any effective therapies. To address this situation, we conducted a preclinical investigation of the therapeutic efficacy of oligonucleotides directed against the oncogenic microRNA miR-221 which has been i...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Park, Jong-Kook, Kogure, Takayuki, Nuovo, Gerard J., Jiang, Jinmai, He, Lei, Kim, Ji Hye, Phelps, Mitch A., Papenfuss, Tracey L., Croce, Carlo M., Patel, Tushar, Schmittgen, Thomas D.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2011
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3773601/
https://ncbi.nlm.nih.gov/pubmed/22009537
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-11-1144
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi